Top Qs
Timeline
Chat
Perspective

1,3-Benzodioxolyl-N-ethylbutanamine

Entactogen, stimulant, and psychedelic designer drug From Wikipedia, the free encyclopedia

1,3-Benzodioxolyl-N-ethylbutanamine
Remove ads

1,3-Benzodioxolyl-N-ethylbutanamine (ethylbenzodioxolylbutanamine, EBDB, or ethyl-J) is a lesser-known entactogen, stimulant, and psychedelic of the phenethylamine, amphetamine, and phenylisobutylamine families. It is the N-ethyl analogue of benzodioxylbutanamine (BDB; "J"), and also the α-ethyl analogue of methylenedioxyethylamphetamine (MDEA; "Eve").

Quick facts Names, Identifiers ...
Remove ads

History

EBDB was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage consumed was 90 mg, and the duration is unknown.[1] EBDB produced few to no effects at the dosage range tested in PiHKAL, but at higher doses of several hundred milligrams it produces euphoric effects similar to those of methylbenzodioxylbutanamine (MBDB; "Eden", "Methyl-J"), although milder and shorter lasting.[citation needed]

Very little data exists about the pharmacological properties, metabolism, and toxicity of EBDB.

Remove ads

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads